# Escitalopram Treatment of Patients With Agitated Dementia

> **NCT00260624** · PHASE4 · COMPLETED · sponsor: **University of Rochester** · enrollment: 20 (estimated)

## Conditions studied

- Alzheimer's Disease
- Psychomotor Agitation

## Interventions

- **DRUG:** Escitalopram (Lexapro)

## Key facts

- **NCT ID:** NCT00260624
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260624, "Escitalopram Treatment of Patients With Agitated Dementia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00260624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
